Finch Therapeutics Group Inc

+0.03 (+5.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)24.72M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.2 Million
Adjusted EPS-$0.41
See more estimates
10-Day MA$0.50
50-Day MA$0.64
200-Day MA$1.77
See more pivots

Finch Therapeutics Group Inc Stock, NASDAQ:FNCH

200 Inner Belt Road, Suite 400, Somerville, Massachusetts 02143
United States of America
Phone: +1.617.229.6499
Number of Employees: 189


Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.